Nurix Therapeutics, Inc. financial statements
Nurix Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 83.98M | 10-K |
| Net income | −USD 264.46M | 10-K |
| Cash and equivalents | USD 246.96M | 10-Q |
Nurix Therapeutics, Inc. financials on 6ix · Nurix Therapeutics, Inc. on 6ix